DIGIPHARM Bringing Value-based Healthcare to life using Blockchain Technology

Digipharms’ solutions aim to accelerate the much needed restructuring of healthcare delivery
systems to a value-based approach. The inherent flaws of current global healthcare infrastructure
result in substantial inefficiency, wastage and sub-optimal health outcomes for the most
important stakeholder; the patient. In healthcare today, there is a lack of incentive for health
systems and providers to focus on mutually beneficial collaboration and the maximisation of
patient outcomes.
Digipharm aims to utilise innovative blockchain technology to overcome barriers to
patient access and innovative pricing, reduce costs for all stakeholders, and bypass
infrastructural limitations to drive value improvement, incentivise innovation and expedite
the transformation to personalised healthcare.
The Reimburse platform harnesses the benefits of automated ‘smart contracts’ and blockchain
technology; facilitating the application of truly dynamic innovative pricing solutions between
healthcare systems and manufacturers, in a secure and compliant fashion with minimal
administrative burden. Use of the Reimburse platform will expedite integration, coordination
and delivery of patient centric healthcare systems with a focus on improving patient outcomes
while accelerating ‘payment for value‘ mechanisms between payers and manufacturers using
neutrally-enforceable agreements in a peer to peer fashion.
The Insights platform will extract anonymised patient level data from the Reimburse platform
and health information systems to the world’s first ‘live’ RWE database. Insights will provide
a symbiotic solution with Reimburse to complement the progressive transformation towards
value-based healthcare delivery systems. The development of a ‘live’ evidence repository
will allow the integration of knowledge back into the delivery system in real time to facilitate
decision making, drug development and health related research. Patients will be incentivised
to contribute their health information to the Insights platform and will gain access to valuable
health information that is currently unattainable.
The digitisation of healthcare is a key element to improving patient outcomes, their
quality of life and reducing the intense burden on health systems worldwide. The
healthcare industry is experiencing a paradigm shift to value-based care due to growth in
demand, aging populations, chronic diseases and unsustainable levels of health related
expenditure. Health systems are transitioning toward value-based care to prevent the
rationing of services and increased costs for patients and payers without compromising
quality of care. Provision of healthcare from a value-based perspective is based on the
underlying aim of generating optimal patient outcomes relative to the monetary spend.
As the fields of diagnostics, molecular medicine and data capture methods develop over time,
it is anticipated that tailored or targeted therapies will become widespread across most disease
areas ushering in a new era of personalised healthcare. Such developments will significantly
transform current industry models for research and development, treatment pathways and
healthcare funding. Digipharm understand the importance and necessity of value-based
healthcare, within such a dynamic environment; and is committed to leading the transformation
of current market access and reimbursement practices worldwide where personalised medicine
becomes the norm and no longer the exception.
TEAM DIGIPHARM

MORE INFORMATION :
WEBSITE : https://www.digipharm.ch/
TWITTER : https://twitter.com/DigipharmTeam
FACEBOOK : https://www.facebook.com/digipharmteam/
Komentar
Posting Komentar